Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial

OBJECTIVES: To assess the cost-effectiveness of cytisine over and above brief behavioural support (BS) for smoking cessation among patients who are newly diagnosed with pulmonary tuberculosis (TB) in low-income and middle-income countries. DESIGN: An incremental cost-utility analysis was undertaken...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinshuo, Parrott, Steve, Keding, Ada, Dogar, Omara, Gabe, Rhian, Marshall, Anna-Marie, Huque, Rumana, Barua, Deepa, Fatima, Razia, Khan, Amina, Zahid, Raana, Mansoor, Sonia, Kotz, Daniel, Boeckmann, Melanie, Elsey, Helen, Kralikova, Eva, Readshaw, Anne, Sheikh, Aziz, Siddiqi, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422837/
https://www.ncbi.nlm.nih.gov/pubmed/36028279
http://dx.doi.org/10.1136/bmjopen-2021-049644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422837/
https://www.ncbi.nlm.nih.gov/pubmed/36028279
http://dx.doi.org/10.1136/bmjopen-2021-049644

Ejemplares similares